HCPCS Code C9301
Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
| Short Description | Obecabtagene car pos t |
|---|---|
| Year | 2026 |
| Coverage Code | D = Special coverage instructions apply |
| Action Code | D = Discontinue procedure or modifier code |
| Action Effective Date | July 01, 2025 |
| Code Added Date | January 01, 2025 |
| Pricing Indicator | 53 = Statute |
| Type of Service | 1 = Medical care |
Cross Reference: Q2058